Real-Time Multimodal AI for Proactive, Individualized Care
5 Key Takeaways
-
1
Real-time multimodal AI can transform cancer care from reactive to proactive, improving consistency and quality across patient visits.
-
2
Current alert systems miss 40% of cases and have low adoption rates due to alarm fatigue and ineffective generic models.
-
3
The Bayesian Health platform integrates multimodal data and employs specialized models to enhance clinical workflows and patient outcomes.
-
4
In a sepsis case study, the platform improved sensitivity and reduced alert volume, leading to significant clinical impact and adoption rates.
-
5
Successful adoption of AI tools in diverse settings requires adaptive technology and workflow design that facilitates ease of use.
ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.